Report From the 20th Meeting of the European Society of Gynaecological Oncology (ESGO 2017)

Razumova

Selçuk

et al. 2020

Self Cite

This is a report from the 21st Meeting of the European Society of Gynaecological Oncology (ESGO 2019) held in Athens, Greece, November 2–5, 2019. The conference offered state of the art educational sessions, and oral and poster abstract presentations. The general sessions throughout the meeting focused not only on prevention, screening, diagnosis, treatment, and translational research but also on emerging trends. Current innovations in gynecological cancers were also discussed. The new rare tumor guidelines project, a joint initiative with the ESGO-Gynecologic Cancer InterGroup, was officially presented for the first time. Moreover, other developments achieved with other societies, such as the European Society for Medical Oncology for ovarian cancer, the European Federation for Colposcopy for cervical cancer prevention and screening, and the European Society for Pediatric Oncology for gynecologic cancers in adolescents, were presented. Here we highlight the key results of the latest gynecological cancer trials that were presented for the first time at ESGO 2019 and added great value to this prestigious scientific congress.

Section: Introductionmentioning

confidence: 91%

Report from the 21st meeting of the European Society of Gynaecological Oncology (ESGO 2019)

Razumova

Selçuk

et al. 2020

Self Cite

“…The European Society of Gynaecological Oncology (ESGO) was founded in 1983 and became one of the largest organizations in the field. The events organized by the society attract participants and key opinion leaders from around the world 1–3. In 2021, the 22nd ESGO meeting was held in a hybrid format for the first time.…”

Section: Introductionmentioning

confidence: 99%

22nd meeting of the European Society of Gynaecological Oncology (ESGO 2021) report

Razumova

Pletnev

et al. 2022

Self Cite

This is a report from the 22nd Meeting of the European Society of Gynaecological Oncology, held October 23–25, 2021. The 3-day event offered an educational experience covering the major scientific and clinical advances in gynecological oncology. The Congress program included different session formats, including guidelines updates and state-of-the-art lectures. This article provides an overview of the main Congress activities as well as of the most important studies that were presented at the event for the first time.

“…The aim of this article is to provide the readers with a collection of short descriptions covering the best original studies presented during the 23rd ESGO Congress. Similar articles prepared by ENYGO authors under the supervision of ESGO experts are available from the previous editions 2–5. All accepted abstracts are published in the supplement to the International Journal of Gynecological Cancer 6…”

Section: Introductionmentioning

confidence: 99%

Best original research presented at the 23rd European Congress on Gynaecological Oncology—Best of ESGO 2022

Kacperczyk‐Bartnik

Ángeles

et al. 2022

Self Cite

Best of ESGO 2022 includes a selection of best original research presented during the 23rd European Congress on Gynaecological Oncology between October 27 and 30, 2022 in Berlin. Out of 1107 submitted abstracts, authors of studies which obtained the highest scores in a blinded review process were invited to present their results during four oral sessions, young investigators session, and oral poster sessions. By means of this publication, we aim to provide readers with an overview of the best quality research presented at the European Society of Gynaecological Oncology (ESGO) 2022.